Navigation Links
Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Micrus Endovascular Corporation
Date:10/4/2007

BENSALEM, Pa., Oct. 4 /PRNewswire/ -- Law Offices of Howard G. Smith announces that a securities class action lawsuit has been filed on behalf of shareholders who purchased the common stock of Micrus Endovascular Corporation ("Micrus" or the "Company")(Nasdaq: MEND) between February 12, 2007 and September 17, 2007, inclusive (the "Class Period"). The class action lawsuit was filed in the United States District Court for the Southern District of Florida.

The Complaint alleges that defendants violated federal securities laws by issuing material misrepresentations to the market concerning the Company's business and prospects, thereby artificially inflating the price of Micrus securities.

No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. If you purchased Micrus shares between February 12, 2007 and September 17, 2007, you have certain rights, and have until December 3, 2007, to move for Lead Plaintiff status. To be a member of the class you need not take any action at this time, and you may retain counsel of your choice. If you wish to discuss this action or have any questions concerning this Notice or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215)638-4847, Toll-Free at (888)638-4847, by email to howardsmithlaw@hotmail.com or visit our website at http://www.howardsmithlaw.com.


'/>"/>
SOURCE Law Offices of Howard G. Smith
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Gigantic Effort: Smoking To Be Banned in British Telecom’s Offices and Van
2. Smoking to be Prohibited at Public Offices in Bangkok from 2008
3. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
4. Iodex goes to SmithKline Beecham consumer Healthcare
5. GlaxoSmithKline To Cultivate Non-Smoking Environment
6. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
7. FDA Mislead On Asthma Drug By GlaxoSmithKline
8. GlaxoSmithKline Defends Its Products
9. GlaxoSmithKline launches diabetes and cancer drugs
10. Generic Products Compete With GlaxoSmithKline
11. New Cervical Cancer Vaccine to Be Launched By Glaxo Smithkline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...t. 6 /PRNewswire/ -- Developed in collaboration wi...ades, CA is introducing,Revolutionary Breast Surfa...c Surgery office of Dr. Steve Laverson this week i...he first of its kind, and is based on,breakthrough...with,innovative proprietary software. The XS-300(T...
(Date:10/6/2008)...ct. 6 /PRNewswire/ -- The organizers of Informex a...e on Global Sourcing for the,Pharmaceutical Indust...inceton Marriott in New Jersey USA., The conferen... the,Global Sourcing Council, and boasts an unpara...e likes of Johnson & Johnson, Bristol Myers Squibb...
(Date:10/6/2008)... LegalView recently posted detailed inform...he potentially serious side effects caused by the ... the drug,s potential side effects are the develop... for young adult and child patients. , ...- LegalView, the number one resource for everythin...
(Date:10/6/2008)... Hospital Ship Serving in West Africa Rece...Garden Valley, Texas October 6, 2008 -- www.seamob...l provider of communications services to remote lo...s to the FoxNews channel via satellite to Mercy Sh...ica Mercy. The Africa Mercy is the world,s larges...
Breaking Medicine News(10 mins):Health News:Plan Your Breasts in 3-D 2Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3
... an increasing number of HIV cases reported among ...ort submitted by the Centre for disease control an...ch// council IDUs in South Africa were sharing and...en if they knew the risks associated with the prac...
...g to the Australian Institute of Health and Welfar...nerates the biggest number of negligence claims//....gligence from this department. Data was collected ...ng through a period of crisis. In this period ther...
...g India is "guarded" on issues related to clinical...are Anbumani Ramadoss has denied that the country ...nical trials in India you have to be transparent. ...t allow our population to suffer,' Ramadoss told r...
...ers have announced a new test to identify patient...ar gene that could be at fault is unveiled today//... study, and they presented their report in the New...xplained that the tests would help to make certain...
Other Medicine News:Health News:A New Test Developed to Identify Suspected Bowel Cancer Patients 2
(Date:10/6/2008)...kinetic Characteristics of Naltrexone SR Associate...cal Trials -, PHOENIX, Oct. 6 /PRNewswire-FirstCa...), a biopharmaceutical company focused on the trea...related disorders, today presented,data showing th... /,bupropion SR), successfully achieved key object...
(Date:10/6/2008)...vealed that drinking polyphenol-rich 100% Concord ...etite, energy intake or body,weight, CONCORD, Mas...100%,polyphenol-rich Concord grape juice did not c...ith changes in appetite and was shown to reduce wa...at the 49th Annual Meeting of,the American College...
(Date:10/3/2008)...and, Oct. 3 /- deCODE genet... an investigational new drug,(IND) application for...or,of phosphodiesterase 4 (PDE4), with the US Food...ing developed as a new and potentially safer means...tive deficits associated,with Alzheimer,s disease ...
(Date:10/2/2008)...iss, Director of Maryland Laser, Skin and Vein,Ins... BALTIMORE, Oct. 2 /- Robert Weiss, M...irst physicians in the U.S. to offer his,patients ...st,state-of-the-art procedure in laser skin resur...ermatologist, who is in private practice in Hunt,V...
Breaking Medicine Technology:Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 2deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 4deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 5DOT Therapy: Newest Breakthrough Technology in Laser Skin Resurfacing 2Zooming in on genetic shuffling 3984 1Zooming in on genetic shuffling 3984 2DNA sewing machine 3979 1UTC Contributes 241 Million to Smilow Cancer Hospital 23698 1UTC Contributes 241 Million to Smilow Cancer Hospital 23698 2Association of Clinical Research Organizations 28ACRO 29 Names Dr Derek Winstanly Chair Elect 2615 1Association of Clinical Research Organizations 28ACRO 29 Names Dr Derek Winstanly Chair Elect 2615 2
...2007 /PRNewswire-FirstCall/ -- Kosan,Biosciences I...s,proprietary nuclear export inhibitors (NEI) show...ing anticancer activity with a,high degree of tole...models. , Kosan,s NEIs are potent, specific inhibi...n that exports key regulatory proteins,("cargo" pr...
...usion Proteins Made by Combining,Cytokines With Pe...,Anti-Tumor Activity With No Observable Toxicity -...PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals...y developing targeted,monoclonal antibodies for th...ion, today reported that data presented at the,Cen...
Other Medicine Technology:Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel,Anticancer Agents, at AACR 2Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel,Anticancer Agents, at AACR 3Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel,Anticancer Agents, at AACR 4Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 2Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 3Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 4
The Pinless Fixator can be applied quickly and easily in the OR or ER to stabilize the fracture and soft tissues without invading the medullary canal, minimizing the risk of infection associated with
...de; Upper extremity fixator has been designed to c...wing independent movement of its clamp in multiple...complexity of frame design, while providing total ...Compact™ system can be used with single or m...
...st Fixator is now available in a convenient, singl...tation. The surgical technique is printed on the i...tor allows the surgeon to restore wrist inclinatio...e frame via joints in the pin clamps, through whic...
The Holding Clamps have a slender design contributes to overall low-profile frame and allow sequential tensioning of Kirschner wires. The Connecting Clamp allows connection of 3.0 mm Carbon Fiber Rod
Medicine Products: